These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 5170476)

  • 21. WHO's global strategy for leprosy elimination.
    Nurs J India; 1994 Feb; 85(2):38-41. PubMed ID: 7937221
    [No Abstract]   [Full Text] [Related]  

  • 22. Eliminating leprosy as a public health problem; why the optimism is justified.
    Noordeen SK
    Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):559-66. PubMed ID: 8642220
    [No Abstract]   [Full Text] [Related]  

  • 23. Views of a health administrator on leprosy control problems.
    Huerta R
    Int J Lepr Other Mycobact Dis; 1968; 36(4):381-90. PubMed ID: 5753809
    [No Abstract]   [Full Text] [Related]  

  • 24. [Epidemiology and control of leprosy in Cuba].
    Sagaró B
    Dermatol Int; 1968; 7(2):95-9. PubMed ID: 5741776
    [No Abstract]   [Full Text] [Related]  

  • 25. DDS chemoprophylaxis for leprosy in children at Culion Sanitarium Palawan, Philippines.
    Lara CB
    Acta Leprol; 1978; (70):35-58. PubMed ID: 104537
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapy of leprosy with sulfonamides. Emphasis on the use of weekly doses.
    Opromolla DV
    Int J Lepr Other Mycobact Dis; 1971; 39(2):467-70. PubMed ID: 4948085
    [No Abstract]   [Full Text] [Related]  

  • 27. Rationale of the multidrug regimens recommended by a World Health Organization Study Group on Chemotherapy of Leprosy for Control Programs.
    Ellard GA
    Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):395-401. PubMed ID: 6541207
    [No Abstract]   [Full Text] [Related]  

  • 28. [Leprosy in Guadeloupe].
    Floch HA
    Bull Soc Pathol Exot Filiales; 1972; 65(1):35-46. PubMed ID: 4677872
    [No Abstract]   [Full Text] [Related]  

  • 29. Leprosy control, elimination and eradication.
    Noordeen SK
    Indian J Lepr; 2000; 72(1):65-8. PubMed ID: 10935187
    [No Abstract]   [Full Text] [Related]  

  • 30. Global and regional annual 'new case detection' of leprosy reported by World Health Organization.
    Noto S; Nunzi E
    Lepr Rev; 2008 Jun; 79(2):124-7. PubMed ID: 18711933
    [No Abstract]   [Full Text] [Related]  

  • 31. Elimination of leprosy: forecasts and projections.
    Gupte MD
    Indian J Lepr; 1994; 66(1):19-35. PubMed ID: 7983389
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current therapeutics in leprosy: resistance--therapeutic regimens--control strategy].
    Nebout M
    Acta Leprol; 1983; 1(3):151-8. PubMed ID: 6359803
    [No Abstract]   [Full Text] [Related]  

  • 33. Multidrug therapy regimen for leprosy.
    Firooz A
    J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
    [No Abstract]   [Full Text] [Related]  

  • 34. Leprosy program in India at the crossroads.
    Rao PN
    Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):211-5. PubMed ID: 16830645
    [No Abstract]   [Full Text] [Related]  

  • 35. Methods of leprosy prevention.
    Crawford CL
    Nature; 1990 May; 345(6274):392. PubMed ID: 2342571
    [No Abstract]   [Full Text] [Related]  

  • 36. Patient compliance with dapsone administration in leprosy.
    Huikeshoven H
    Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):228-58. PubMed ID: 7024150
    [No Abstract]   [Full Text] [Related]  

  • 37. Trends in leprosy case detection worldwide since 1985.
    Meima A; Richardus JH; Habbema JD
    Lepr Rev; 2004 Mar; 75(1):19-33. PubMed ID: 15072123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leprosy treatment and control of leprosy in India. (Assessment of achievements and suggestions for the future).
    Chatterjee SN
    Lepr India; 1980 Oct; 52(4):573-81. PubMed ID: 7193261
    [No Abstract]   [Full Text] [Related]  

  • 39. Leprosy in children aged 0-14 years: report of an 11-year control programme.
    Keller R; Deen RD
    Lepr Rev; 1985 Sep; 56(3):239-48. PubMed ID: 4058234
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prevalence of dapsone-resistant leprosy in Burundi. Temporary results].
    Bourland J; Van Loo L; Pattyn SR
    Acta Leprol; 1982; (86-87):29-33. PubMed ID: 6815995
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.